Regazzoli Damiano, Leone Pier Pasquale, Colombo Antonio, Latib Azeem
Interventional Cardiology Unit, Cardiology and Cardiothoracic Surgery Department, San Raffaele University Hospital, Milan, Italy.
Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan, Italy.
J Thorac Dis. 2017 Aug;9(Suppl 9):S979-S985. doi: 10.21037/jtd.2017.07.104.
Bioresorbable scaffolds (BRS) represent a novel horizon in interventional cardiology and may lead to some potential long-term advantages including the restoration of vasomotion, positive remodeling and a reduced incidence of late and very-late scaffold thrombosis (ScT). This technology, introduced to overcome limitations of current metallic drug-eluting stents (DES), is constantly and rapidly evolving with many companies working on bioresorbable devices. The aim of this review is to present an update on the most promising scaffolds that are under development.
生物可吸收支架(BRS)代表了介入心脏病学的一个新领域,可能带来一些潜在的长期优势,包括血管运动恢复、正向重塑以及降低晚期和极晚期支架血栓形成(ScT)的发生率。这项旨在克服当前金属药物洗脱支架(DES)局限性而引入的技术正在不断快速发展,许多公司都在致力于生物可吸收装置的研发。本综述的目的是介绍正在开发的最有前景的支架的最新情况。